CAI Hongbing
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR Mutation (NCT04473339) | CAI Hongbing | 2020-08-01 |
Track CAI Hongbing automatically
Every clearance here is in the API, with alerts when new ones post.